A novel mutation in the VMD2 gene in an Italian family with Best maculopathy

被引:15
作者
Sodi, A.
Passerini, I.
Simonelli, F.
Testa, F.
Menchini, U.
Torricelli, F.
机构
[1] Univ Florence, Dept Oto Neuro Ophthalmol Surg Sci, I-50134 Florence, Italy
[2] Careggi Univ Hosp, Dept Genet Diagnost, Florence, Italy
[3] Univ Naples 2, Eye Clin, Naples, Italy
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2007年 / 30卷 / 06期
关键词
best disease; VMD2; gene; mutation analysis; choroidal neovascularisation;
D O I
10.1016/S0181-5512(07)89667-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Vitelliform macular dystrophy (Best disease) is an inherited macular degeneration in which the primary defect is thought to occur at the level of the retinal pigment epithelium. The VMD2 gene, considered responsible for the disease, mapped to the long arm of chromosome 11, and it codifies the bestrophin protein, probably acting as a transmembrane ionic channel. In the present study, we screened for mutations the VMD2 gene in Italian patients with Best maculopathy. Five families with Best disease were recruited from central and southern ltaly, and family members were evaluated by complete ophthalmologic examination and DNA analysis by means of DHPLC technology. Some mutations of the VMD2 gene were identified and among them there was a novel mutation (R218G), probably involving a functionally active region of the bestrophin protein. In spite of the small number of families considered, it was possible to note a significant phenotypic heterogeneity. First, in one family the R218C mutation was associated with early onset of choroidal neovascularization (CNV) in the affected mother and her son, while no CNV was reported in another family sharing the same mutation. Then a patient with the R25W mutation showed a multifocal location of the vitelliform deposits, while another family with the same mutation showed a typical isolated vitelliform disc in the macular area.
引用
收藏
页码:616 / 620
页数:5
相关论文
共 25 条
[1]   The mutation spectrum of the bestrophin protein - functional implications [J].
Bakall, B ;
Marknell, T ;
Ingvast, S ;
Koisti, MJ ;
Sandgren, O ;
Li, W ;
Bergen, AAB ;
Andreasson, S ;
Rosenberg, T ;
Petrukhin, K ;
Wadelius, C .
HUMAN GENETICS, 1999, 104 (05) :383-389
[2]  
Best F., 1905, Z AUGENHEILKD, V13, P199, DOI [DOI 10.1159/000290318, 10.1159/000290318]
[3]   Bestrophin gene mutations in patients with best vitelliform macular dystrophy [J].
Caldwell, GM ;
Kakuk, LE ;
Griesinger, IB ;
Simpson, SA ;
Nowak, NJ ;
Small, KW ;
Maumenee, IH ;
Rosenfeld, PJ ;
Sieving, PA ;
Shows, TB ;
Ayyagari, R .
GENOMICS, 1999, 58 (01) :98-101
[4]   ELECTROOCULOGRAPHY IN BESTS MACULAR DYSTROPHY [J].
CROSS, HE ;
BARD, L .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1974, 77 (01) :46-50
[5]  
Glacet-Bernard A, 1993, Eur J Ophthalmol, V3, P53
[6]  
Kramer Franziska, 2003, Hum Mutat, V22, P418, DOI 10.1002/humu.9189
[7]  
Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291
[8]   Hereditary retinal dystrophies and choroidal neovascularization [J].
Marano, F ;
Deutman, AF ;
Leys, A ;
Aandekerk, AL .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2000, 238 (09) :760-764
[9]  
Marchant D, 2002, Ophthalmic Genet, V23, P167, DOI 10.1076/opge.23.3.167.7880
[10]  
Marchant D, 2001, Hum Mutat, V17, P235, DOI 10.1002/humu.9